Language selection

Search

Patent 2802333 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2802333
(54) English Title: SYSTEMS AND METHODS FOR MAKING AND USING ELECTRICAL STIMULATION SYSTEMS HAVING MULTI-LEAD-ELEMENT LEAD BODIES
(54) French Title: SYSTEMES ET PROCEDES DE FABRICATION ET D'UTILISATION DE SYSTEMES DE STIMULATION ELECTRIQUE AYANT DES CORPS DE DERIVATION A ELEMENTS DE DERIVATION MULTIPLES
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61N 01/05 (2006.01)
(72) Inventors :
  • BARKER, JOHN MICHAEL (United States of America)
(73) Owners :
  • BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
(71) Applicants :
  • BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (United States of America)
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 2011-07-18
(87) Open to Public Inspection: 2012-02-02
Examination requested: 2016-05-18
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US2011/044395
(87) International Publication Number: US2011044395
(85) National Entry: 2012-12-10

(30) Application Priority Data:
Application No. Country/Territory Date
61/368,943 (United States of America) 2010-07-29

Abstracts

English Abstract

A lead for providing electrical stimulation of patient tissue includes a distal lead element, at least two proximal lead elements, and a junction coupling the distal lead element to each of the at least two proximal lead elements. The distal lead element includes a plurality of electrodes and a plurality of conductive wires coupled to the plurality of electrodes and extending along a longitudinal axis of the distal lead element. Each of the at least two proximal lead elements includes a plurality of terminals and a plurality of conductive wires coupled to the plurality of terminals and extending along a longitudinal axis of the proximal lead element. The junction includes a circuit arrangement electrically coupling each of the conductive wires of the distal lead element to at least one of the conductive wires of at least one of the at least two proximal lead elements.


French Abstract

L'invention concerne une dérivation pour la fourniture d'une stimulation électrique à un tissu de patient, laquelle dérivation comprend un élément de dérivation distal, au moins deux éléments de dérivation proximaux, et une jonction couplant l'élément de dérivation distal à chacun des au moins deux éléments de dérivation proximaux. L'élément de dérivation distal comprend une pluralité d'électrodes et une pluralité de fils conducteurs couplés à la pluralité d'électrodes et s'étendant le long d'un axe longitudinal de l'élément de dérivation distal. Chacun des au moins deux éléments de dérivation proximaux comprend une pluralité de bornes et une pluralité de fils conducteurs couplés à la pluralité de bornes et s'étendant le long d'un axe longitudinal de l'élément de dérivation proximal. La jonction comprend un agencement de circuits couplant électriquement chacun des fils conducteurs de l'élément de dérivation distal à au moins l'un des fils conducteurs d'au moins l'un des au moins deux éléments de dérivation proximaux.

Claims

Note: Claims are shown in the official language in which they were submitted.


CLAIMS
What is claimed as new and desired to be protected by Letters Patent of the
United
States is:
1. A lead for providing electrical stimulation of patient tissue, the lead
comprising:
a distal lead element comprising
a plurality of electrodes disposed on the distal lead element, and
a plurality of conductive wires coupled to the plurality of electrodes and
extending along a longitudinal axis of the distal lead element;
at least two proximal lead elements, each of the at least two proximal lead
elements comprising
a plurality of terminals disposed on the proximal lead element, and
a plurality of conductive wires coupled to the plurality of terminals and
extending along a longitudinal axis of the proximal lead element; and
a junction coupling the distal lead element to each of the at least two
proximal
lead elements, the junction comprising a circuit arrangement electrically
coupling each of
the conductive wires of the distal lead element to at least one of the
conductive wires of at
least one of the at least two proximal lead elements.
2. The lead of claim 1, wherein the circuit arrangement comprises a flexible
substrate and a plurality of conductive junction elements at least partially
disposed
on the substrate.
3. The lead of claim 2, wherein the conductive junction elements are each
coupled to at least one non-conductive spine.
4. The lead of claim 1, wherein the circuit arrangement comprises a flex
circuit.
-22-

5. The lead of claim 1, wherein the circuit arrangement is rolled up within
the
junction.
6. The lead of claim 1, wherein the circuit arrangement is folded up within
the junction.
7. The lead of claim 1, wherein a first lumen is defined in the distal lead
element and a second lumen is defined in a one of the proximal lead elements.
8. The lead of claim 7, wherein the junction further comprises a transition
tube coupling the first lumen to the second lumen to form a continuous passage
between
the first lumen and the second lumen configured and arranged to receive a
stylet.
9. The lead of claim 8, wherein the circuit arrangement is rolled up around
the transition tube.
10. The lead of claim 1, wherein a first one of the proximal lead elements has
a length that is different from a second one of the at least two proximal lead
elements.
11. An electrical stimulating system comprising:
the lead of claim 1;
at least one control module configured and arranged to electrically couple to
each
of the proximal lead elements, each of the at least one control module
comprising
a housing, and
an electronic subassembly disposed in the housing; and
a connector for receiving at least one of the at least two proximal lead
elements,
the connector having a proximal end, a distal end, and a length, the connector
configured
and arranged to receive at least one of the two proximal lead elements, the
connector
comprising
-23-

a connector housing defining at least one port at the distal end of the
connector, the at least one port configured and arranged for receiving at
least one
of the two proximal lead elements, and
a plurality of connector contacts disposed in the connector housing, the
connector contacts configured and arranged to couple to at least one of the
plurality of terminals disposed on each of the at least one of the two
proximal lead
elements.
12. A kit for providing electrical stimulation of patient tissue during atrial
stimulation, the kit comprising:
the lead of claim 1; and
a lead introducer for facilitating insertion of the trial stimulation lead
into the
patient, the lead introducer comprising
an outer member configured and arranged for insertion into the patient,
and
an insertion needle configured and arranged for insertion into the outer
member, the insertion needle also configured and arranged to receive the
distal
lead element.
13. The kit of claim 12, further comprising a stylet for facilitating guidance
of
the electrodes to a target stimulation region within the patient, the stylet
configured and
arranged for insertion into the first lumen of the distal lead element and the
second lumen
of one of the at least two proximal lead elements.
14. The kit of claim 12, wherein the outer member is configured and arranged
to divide into at least two parts for removal of the outer member from the
distal lead
element upon insertion of the lead into the patient.
15. The kit of claim 12, wherein the insertion needle defines an open channel
configured and arranged to receive at least a portion of the distal lead
element.
-24-

16. The kit of claim 12, wherein the insertion needle comprises a plurality of
body lead elements configured and arranged to at least partially separate from
one another
upon removal of the outer member.
17. A method of fabricating a lead, the method comprising
providing a plurality of electrodes on a distal lead element;
providing a plurality of first terminals on a first proximal lead element;
providing a plurality of second terminals on a second proximal element;
electrically coupling a plurality of conductive wires to the plurality of
electrodes
and extending the conductive wires along a longitudinal length of the distal
lead element;
electrically coupling a plurality of conductive wires to the plurality of
first
terminals and extending the conductive wires along a longitudinal length of
the first
proximal lead element;
electrically coupling a plurality of conductive wires to the plurality of
second
terminals and extending the conductive wires along a longitudinal length of
the second
proximal lead element;
electrically coupling each of the conductive wires of the distal lead element
to at
least one of the conductive wires of either of the first proximal lead element
or the second
proximal lead element using a circuit arrangement;
inserting the circuit arrangement into a junction; and
coupling the distal lead element, the first proximal lead element and the
second
proximal lead element to the junction.
18. The method of claim 17, wherein inserting the circuit arrangement into the
junction comprises rolling up the circuit arrangement and inserting the
circuit
arrangement into the junction.
19. The method of claim 18, wherein rolling up the circuit arrangement
comprises rolling up the circuit arrangement around a transition tube coupled
at one end
to a lumen defined in the distal lead element and coupled at another end to a
lumen
defined in the first proximal lead element.
-25-

20. The method of claim 17, further comprising center-less grinding at least
one of the distal lead element, the first proximal lead element, or the second
proximal
lead element prior to electrically coupling each of the conductive wires of
the distal lead
element to at least one of the conductive wires of either of the first
proximal lead element
or the second proximal lead element using a circuit arrangement.
-26-

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
SYSTEMS AND METHODS FOR MAKING AND USING ELECTRICAL
STIMULATION SYSTEMS HAVING MULTI-LEAD-ELEMENT LEAD BODIES
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of U.S. Provisional Patent Application
Serial
No. 61/368,943 filed on July 29, 2010, which is incorporated herein by
reference.
FIELD
The present invention is directed to the area of implantable electrical
stimulation
systems and methods of making and using the systems. The present invention is
also
directed to implantable electrical stimulation leads having lead bodies with
multiple lead
elements coupled to one another via circuit arrangements, as well as methods
of making
and using the leads, lead bodies, lead elements, and electrical stimulation
systems.
BACKGROUND
Implantable electrical stimulation systems have proven therapeutic in a
variety of
diseases and disorders.. For example, spinal cord stimulation systems have
been used as a
therapeutic modality for the treatment of chronic pain syndromes. Peripheral
nerve
stimulation has been used to treat chronic pain syndrome and incontinence,
with a number
of other applications under investigation. Functional electrical stimulation
systems have
been applied to restore some functionality to paralyzed extremities in spinal
cord injury
patients.
Stimulators have been developed to provide therapy for a variety of
treatments. A
stimulator can include a control module (with a pulse generator), one or more
leads, and
an array of stimulator electrodes on each lead. The stimulator electrodes are
in contact
with or near the nerves, muscles, or other tissue to be stimulated. The pulse
generator in
the control module generates electrical pulses that are delivered by the
electrodes to body
tissue.
BRIEF SUMMARY
In one embodiment, a lead for providing electrical stimulation of patient
tissue
includes a distal lead element, at least two proximal lead elements, and a
junction
coupling the distal lead clement to each of the at least two proximal lead
elements, The
-1-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
distal lead element includes a plurality of electrodes and a plurality of
conductive wires
coupled to the plurality of electrodes and extending along a longitudinal axis
of the distal
lead element. Each of the at least two proximal lead elements includes a
plurality of
terminals and a plurality of conductive wires coupled to the plurality of
terminals and
extending along a longitudinal axis of the proximal lead element. The junction
includes a
circuit arrangement electrically coupling each of the conductive wires of the
distal lead
element to at least one of the conductive wires of at least one of the at
least two proximal
lead elements.
In another embodiment, a method of fabricating a lead includes providing a
plurality of electrodes on a distal lead element, providing a plurality of
first terminals on a
first proximal lead element, and providing a plurality of second terminals on
a second
proximal element. A plurality of conductive wires are electrically coupled to
the plurality
of electrodes and are extended along a longitudinal length of the distal lead
element. A
plurality of conductive wires are electrically coupled to the plurality of
first terminals and
are extended along a longitudinal length of the first proximal lead element, A
plurality of
conductive wires are electrically coupled to the plurality of second terminals
and are
extended along a longitudinal length of the second proximal lead element. Each
of the
conductive wires of the distal lead element are electrically coupled to at
least one of the
conductive wires of either of the first proximal lead element or the second
proximal lead
element using a circuit arrangement. The circuit arrangement is inserted into
a junction.
The distal lead element, the first proximal lead element and the second
proximal lead
element are coupled to the junction.
BRIEF DESCRIPTION OF THE DRAWINGS
Non-limiting and non-exhaustive embodiments of the present invention are
described with reference to the following drawings. In the drawings, like
reference
numerals refer to like parts throughout the various figures unless otherwise
specified.
For a better understanding of the present invention, reference will be made to
the
following Detailed Description, which is to be read in association with the
accompanying
drawings, wherein:
FIG. I is a schematic view of one embodiment of an electrical stimulation
system,
according to the invention;
-2-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
FIG. 2 is a schematic view of another embodiment of an electrical stimulation
system, according to the invention;
FIG. 3A is a schematic view of one embodiment of a proximal portion of a lead
and a control module of an electrical stimulation system, according to the
invention;
FIG. 3B is a schematic view of one embodiment of a proximal portion of a lead
and a lead extension of an electrical stimulation system, according to the
invention;
FIG. 4 is a schematic perspective view of one embodiment of a lead with a lead
body that includes a distal lead element coupled to proximal lead elements via
a junction,
according to the invention;
FIG. 5 is a schematic perspective exploded view of one embodiment of the lead
of
FIG. 4, the lead including a circuit arrangement to which conductive wires
extending
from the lead elements of FIG. 4 are coupleable, according to the invention;
FIG. 6 is a schematic side view of one embodiment of the circuit arrangement
of
FIG. 5 coupling conductive wires of the distal lead element of FIG. 4 to
conductive wires
of the proximal lead elements of FIG. 5, according to the invention;
FIG. 7 is a schematic longitudinal cross-sectional view of one embodiment of
the
distal lead element of FIG. 4 coupled to one of the proximal lead elements of
FIG. 4 via
the circuit arrangement of FIG. 5, according to the invention;
FIG. 8 is a schematic perspective view of one embodiment of the circuit
arrangement of FIG. 5 coupling conductive wires from the distal lead element
of FIG. 4
to conductive wires of the proximal lead elements of FIG. 4, the circuit
arrangement
rolled up and disposed in a junction, according to the invention;
FIG. 9 is a schematic transverse cross-sectional view of one embodiment of the
rolled up circuit arrangement of FIG. 8, according to the invention;
FIG. 10 is a schematic longitudinal transverse cross-sectional view of one
embodiment of a transition tube extending through the junction of FIG. 4 from
a lumen of
the distal lead element of FIG. 4 to a lumen of one of the proximal lead
elements of FIG.
4, according to the invention;
-3-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
FIG. I I is a schematic transverse cross-sectional view of one embodiment of
the
transition tube of FIG. 10 extending through the rolled up circuit arrangement
of FIG. 8,
according to the invention;
FIG. 12 is a schematic perspective view of one embodiment of a lead introducer
that includes an outer member that splits to separate from a trial lead,
according to the
invention;
FIG. 13A is a schematic perspective view of one embodiment of a lead and a
body
lead clement of an insertion needle, the body lead element defining an open
channel
extending along a length of the body lead element, the open channel configured
and
arranged to receive the trial lead, according to the invention;
FIG, 138 is a schematic transverse cross-section al view of several exemplary
embodiments of the open channel of the body lead element of FIG. 13A,
according to the
invention;
FIG. 14A is a schematic longitudinal cross-sectional view of one embodiment of
a
lead introducer with an outer member disposed over a split-release insertion
needle,
according to the invention;
FIG. 14B is a schematic transverse cross-sectional view of one embodiment of
the
lead introducer of FIG. 14A, according to the invention; and
FIG. 15 is a schematic overview of one embodiment of components of a
stimulation system, including an electronic subassembly disposed within a
control
module, according to the invention.
DETAILED DESCRIPTION
The present invention is directed to the area of implantable electrical
stimulation
systems and methods of making and using the systems. The present invention is
also
directed to implantable electrical stimulation leads having lead bodies with
multiple lead
elements coupled to one another via circuit arrangements, as well as methods
of making
and using the leads, lead bodies, lead elements, and electrical stimulation
systems.
-4-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
Suitable implantable electrical stimulation systems include, but are not
limited to,
an electrode lead ("lead") with one or more electrodes disposed on a distal
end of the lead
and one or more terminals disposed on one or more proximal ends of the lead.
Leads
include, for example, percutaneous leads, paddle leads, and cuff leads.
Examples of
electrical stimulation systems with leads are found in, for example, U.S.
Patents Nos.
6,181,969; 6,516,227; 6,609,029; 6,609,032; 6,741,892; 7,244,150; 7,672,734;
and
7,761,165; and U.S. Patent Applications Publication Nos. 2003/0 1 1 4905,
2005/0165465,
2007/0150036; 2007/02 1 95 95; 2007/0239243; and 2008/0071320, all of which
are
incorporated by reference.
Figure 1 illustrates schematically one embodiment of an electrical stimulation
system 100. The electrical stimulation system includes a control module (e.g.,
a
stimulator or pulse generator) 102, a paddle body 104, and at least one lead
body 106
coupling the control module 102 to the paddle body 104. The paddle body 104
and the
one or more lead bodies 106 form a lead. The paddle body 104 typically
includes an
1.5 array of electrodes 134. The control module 102 typically includes an
electronic
subassembly 110 and an optional power source 120 disposed in a sealed housing
114.
The control module 102 typically includes a connector 144 (Figure 2 and 3A,
see also 322
and 350 of Figure 3B) into which the proximal end of the one or more lead
bodies 106
can be plugged to make an electrical connection via conductive contacts on the
control
module 102 and terminals (e.g., 310 in Figure 3A and 336 of Figure 3B) on each
of the
one or more lead bodies 106. It will be understood that the electrical
stimulation system
can include more, fewer, or different components and can have a variety of
different
configurations including those configurations disclosed in the electrical
stimulation
system references cited herein. For example, instead of a paddle body 104, the
electrodes
134 can be disposed in an array at or near the distal end of the lead body 106
forming a
percutaneous lead, as illustrated in Figure 2. A percutaneous lead may be
isodiametric
along the length of the lead. In addition, one or more lead extensions 312
(see Figure 3B)
can be disposed between the one or more lead bodies 106 and the control module
102 to
extend the distance between the one or more lead bodies 106 and the control
module 102
of the embodiments shown in Figures 1 and 2.
The electrical stimulation system or components of the electrical stimulation
system, including one or more of the lead bodies 106, the paddle body 104, and
the
-5-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
control module 102, are typically implanted into the body of a patient. The
electrical
stimulation system can be used for a variety of applications including, but
not limited to,
brain stimulation, neural stimulation, spinal cord stimulation, muscle
stimulation, and the
like.
The electrodes 134 can be formed using any conductive, biocompatible material.
Examples of suitable materials include metals, alloys, conductive polymers,
conductive
carbon, and the like, as well as combinations thereof. The number of
electrodes 134 in
the array of electrodes 134 may vary. For example, there can be two, four,
six, eight, ten,
twelve, fourteen, sixteen, or more electrodes 134. As will be recognized,
other numbers
of electrodes 134 may also be used.
The electrodes of the paddle body 104 or one or more lead bodies 106 are
typically disposed in, or separated by, a non-conductive, biocompatible
material
including, for example, silicone, polyurethane, polyetheretherketone ("PEEK"),
epoxy,
and the like or combinations thereof. The paddle body 104 and one or more lead
bodies
106 may be formed in the desired shape by any process including, for example,
molding
(including injection molding), casting, and the like. Electrodes and
connecting wires can
be disposed onto or within a paddle body either prior to or subsequent to a
molding or
casting process. The non-conductive material typically extends from the distal
end of the
lead to the proximal end of each of the one or more lead bodies 106. The non-
conductive,
biocompatible material of the paddle body 104 and the one or more lead bodies
106 may
be the same or different. The paddle body 104 and the one or more lead bodies
106 may
be a unitary structure or can be formed as two separate structures that are
permanently or
detachably coupled together.
Terminals (e.g., 310 in Figure 3A and 336 of Figure 3B) are typically disposed
at
the proximal end of the one or more lead bodies 106 for connection to
corresponding
conductive contacts (e.g., 314 in Figure 3A and 340 of Figure 3B) in
connectors (e.g., 144
in Figures 1-3A and 322 and 350 of Figure 3B) disposed on, for example, the
control
module 102 (or to other devices, such as conductive contacts on a lead
extension, an
operating room cable, or an adaptor). Conductive wires ("conductors") (not
shown)
extend from the terminals (e.g., 310 in Figure 3A and 336 of Figure 3B) to the
electrodes
134. Typically, one or more electrodes 134 are electrically coupled to a
terminal (e.g.,
310 in Figure 3A and 336 of Figure 3B). In some embodiments, each terminal
(e.g., 310
-6-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
in Figure 3A and 336 of Figure 3B) is only connected to one electrode 134. The
conductive wires may be embedded in the non-conductive material of the lead or
can be
disposed in one or more lumens (not shown) extending along the lead. In some
embodiments, there is an individual lumen for each conductive wire. In other
embodiments, two or more conductive wires may extend through a lumen. There
may
also be one or more lumens (not shown) that open at, or near, the proximal end
of the
lead, for example, for inserting a stylet rod to facilitate placement of the
lead within a
body of a patient. Additionally, there may also be one or more lumens (not
shown) that
open at, or near, the distal end of the lead, for example, for infusion of
drugs or
medication into the site of implantation:of the paddle body 104. In at least
one
embodiment, the one or more lumens may be flushed continually, or on a regular
basis,
with saline, epidural fluid, or the like. In at least some embodiments, the
one or more
lumens can be permanently or removably sealable at the distal end.
In at least some embodiments, leads are coupled to connectors disposed on
control
modules. In Figure 3A, a lead 308 is shown configured and arranged for
insertion to the
control module 102. The connector 144 includes a connector housing 302. The
connector housing 302 defines at least one port 304 into which a proximal end
306 of a
lead 308 with terminals 310 can be inserted, as shown by directional arrow
312. The
connector housing 302 also includes a plurality of conductive contacts 314 for
each port
304. When the lead 308 is inserted into the port 304, the conductive contacts
314 can be
aligned with the terminals 310 on the lead 308 to electrically couple the
control module
102 to the electrodes (134 of Figure 1) disposed at a distal end of the lead
308. Examples
of connectors in control modules are found in, for example, U.S. Patent No.
7,244,150
and U.S. Patent Application Serial No. 11/532,844, which are incorporated by
reference.
In Figure 3B, a connector 322 is disposed on a lead extension 324. The
connector
322 is shown disposed at a distal end 326 of the lead extension 324. The
connector 322
includes a connector housing 328. The connector. housing 328 defines at least
one port
330 into which a proximal end 332 of a lead 334 with terminals 336 can be
inserted, as
shown by directional arrow 338. The connector housing 328 also includes a
plurality of
conductive contacts 340. When the lead 334 is inserted into the port 330, the
conductive
contacts 340 disposed in the connector housing 328 can be aligned with the
terminals 336
-7-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
on the lead 334 to electrically couple the lead extension 324 to the
electrodes (134 of
Figure 1) disposed at a distal end (not shown) of the lead 334.
In at least some embodiments, the proximal end of a lead extension is
similarly
configured and arranged as a proximal end of a lead. The lead extension 324
may include
a plurality of conductive wires (not shown) that electrically couple the
conductive
contacts 340 to a proximal end 348 of the lead extension 324 that is opposite
to the distal
end 326. In at least some embodiments, the conductive wires disposed in the
lead
extension 324 can be electrically coupled to a plurality of terminals (not
shown) disposed
on the proximal end 348 of the lead extension 324. In at least some
embodiments, the
proximal end 348 of the lead extension 324 is configured and arranged for
insertion into a
connector disposed in another lead extension. In other embodiments, the
proximal end
348 of the lead extension 324 is configured and arranged for insertion into a
connector
disposed in a control module. As an example, in Figure 3B the proximal end 348
of the
lead extension 324 is inserted into a connector 350 disposed in a control
module 352.
In at least some embodiments, the lead includes a lead body having a plurality
of
lead elements, a "multi-lead-element lead body." The multi-lead-element lead
body
includes a distal lead element and one or more proximal lead elements. The
distal lead
element is coupled to the one or more proximal lead elements via a junction, A
plurality
of electrodes are disposed on the distal lead element. A plurality of
conductive wires are
electrically coupled to the electrodes and extend along the distal lead
element to the
junction. A plurality of terminals are disposed one each of the proximal lead
elements. A
plurality of conductive wires are electrically coupled to the terminals and
extend along
the proximal lead elements to the junction. A circuit arrangement is disposed
in the
junction and electrically couples the conductive wires of the distal lead
element to one or
more conductive wires of one or more proximal lead elements. In at least some
embodiments, the circuit arrangement is configured and arranged to roll up.
As described above, in at least some embodiments the electrodes are configured
and arranged for implantation into an epidural space of a patient. In at least
some
embodiments, the terminals are configured and arranged for insertion into a
connector
disposed on, for example, a control module, a lead extension, an operating
room cable, an
external trial stimulator, or the like or combinations thereof. It will be
understood that the
-8-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
multi-lead-element lead body may be used with many different lead
configurations,
including a paddle lead (sec e.g., Figure 1) or a percutaneous lead (see e.gõ
Figure 2).
It may be an advantage to couple a distal lead element to one or more proximal
lead elements via a junction because it may increase manufacturing
flexibility. For
example, the lead can be manufactured with any number of lead elements. Also,
lead
elements can be manufactured with different lengths, widths, terminal or
electrode
arrangements, or the like. It may also reduce cost, for example, by enabling
malfunctioning portions of the lead to be replaced without replacing the
entire lead.
Another reason for manufacturing the lead in separate elements is to allow
center-less
grinding of each contact array (e.g., terminals and electrodes) before joining
the elements
together at the junction, otherwise the junction and other two proximal lead
elements may
flop around in the grinder during grinding of each array if pre joined.
Figure 4 is a schematic perspective view of one embodiment of a lead 400 that
includes a multi-lead-clement lead body 402. The multi-lead-element lead body
402
includes a distal lead element 404 and proximal lead elements 406a and 406b.
The distal
lead element 404 is coupled to the proximal lead elements 406a and 406b via a
junction
408. In at least some embodiments, a plurality of electrodes 410 are disposed
on the
distal lead element 404. In at least some embodiments, a plurality of
terminals 412a and
412b are disposed on one or more of the proximal lead elements 406a and 406b,
respectively. In at least some embodiments, the lead 400 is configured and
arranged for
attachment to a conventional implantable pulse generator.
The distal and proximal lead elements can be any length. In preferred
embodiments, the distal lead element is longer than the one or more proximal
lead
elements. In at least some embodiments, however, the one or more proximal lead
elements are at least as long as the distal lead element. In at least some
embodiments,
when the lead body includes multiple proximal lead elements, at least two of
the proximal
lead elements have different lengths from one another. In at least some
embodiments,
each of the lead elements have equal diameters. In at least some embodiments,
the distal
lead element has a larger diameter than the one or more proximal lead
elements. In at
least some other embodiments, the distal lead element has a smaller diameter
than the one
or more proximal lead elements.
-9-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
In at least some embodiments, a circuit arrangement is disposed in the
junction
408. In at least some embodiments, the electrodes 410 are electrically coupled
to the one
or more of the terminals 412a or 412b via the circuit arrangement. In at least
some
embodiments, the circuit arrangement can be rolled or folded up and inserted
into the
junction 408 (e.g., a molded portion of the junction 408, or the like).
Figure 5 is a schematic perspective exploded view of one embodiment of the
lead
400. The distal lead element 404 includes a plurality of conductive wires 502
coupled to
the electrodes 410 and extending along a longitudinal axis of the distal lead
element 404
to a proximal end of the distal lead element 404. In Figure 5, the conductive
wires 502
are shown extending outwardly from the proximal end of the distal lead element
404.
The proximal lead element 406a includes a plurality of conductive wires 504a
coupled to
the terminals 412a and extending along a longitudinal axis of the proximal
lead element
406a to a distal end of the proximal lead element 406a. In Figure 5, the
conductive wires
504a are shown extending outwardly from the distal end of the proximal lead
element
406a. Similarly, the proximal lead element 406b includes a plurality of
conductive wires
504b coupled to the terminals 4126 and extending along a longitudinal axis of
the
proximal lead element 406b to a distal end of the proximal lead element 406b.
In Figure
5, the conductive wires 504b are shown extending outwardly from the distal end
of the
proximal lead element 406b.
A circuit arrangement 510 is disposed between the conductive wires 502, 504a,
and 504b. As discussed above, the circuit arrangement 510 electrically couples
each of
the conductive wires 502 to one or more of the conductive wires 504a or 504b.
In at least
some embodiments, the number of conductive wires 502 is equal to the number of
electrodes 410. In at least some embodiments, the number of conductive wires
502 is
equal to the number of conductive wires 504a plus the number of conductive
wires 504b.
In at least some embodiments, the number of conductive wires 504a is equal to
the
number of terminals 412a. In at least some embodiments, the number of
conductive wires
504b is equal to the number of terminals 412b. In at least some embodiments,
the number
of conductive wires 504a is equal to the number of conductive wires 504b. In
at least
some embodiments, one or more of the conductive wires 502, 504a, or 504b
differ in
diameter, materials, or configuration from at least one other of the
conductive wires 502,
504a, or 504b. In at least some embodiments, each of the conductive wires 502,
504a, or
-10-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
504b are equivalent in at least one of diameter, materials, or configuration
from at least
one other of the conductive wires 502, 504a, or 504b. In at least some
embodiments, each
individual conductive wire 502 couples to one and only one of the conductive
wires 504a,
504b.
In at least some embodiments, the number of electrodes 410 is equal to the
number of the terminals 412a plus the number of the terminals 412b. In at
least some
embodiments, the number of terminals 412a is equal to the number of terminals
412b.
The distal lead element 404, can include any number of electrodes including,
for example,
two, three, four, five, six, seven, eight, nine, ten, eleven, twelve,
fourteen, sixteen, twenty,
twenty-four, thirty-two, forty, or more electrodes. The proximal lead elements
406a and
406b can include any number of terminals including, for example, one, two,
three, four,
five, six, seven, eight, nine, ten, eleven, twelve, fourteen, sixteen, or more
terminals.
Figure 6 is a schematic side view of one embodiment of the conductive wires
502,
504a, and 504b coupled to the circuit arrangement 510, which is laid out in a
relatively
flat configuration. In at least some embodiments, the circuit arrangement 510
includes an
array of conductive junction elements 602 embedded within a non-conductive
flexible
substrate 604. In at least some embodiments, the conductive junction elements
602 are
stamped or laser cut. In at least some embodiments, flexible substrate 604 on
which the
conductive junction elements 602 are embedded is a polymer sheet (e.g.,
silicone, or the
like).
In at least some embodiments, conductive junction elements 602 include one or
more tracings. In at least some embodiments, the conductive junction elements
602
include one or more conductive struts. In at least some embodiments, an
insulating jacket
606 is disposed over at least one of the circuit arrangement 510 or the
junction 408. In at
least some embodiments, the insulating jacket 606 includes one or more
adhesive strips
for holding one or more of the conductive junction elements 602 in place.
In alternate embodiments, the circuit arrangement 510 includes a printed
circuit
disposed on a flexible substrate, or a "flex circuit." In at least some
embodiments, the
flexible substrate on which the printed circuit arrangement is disposed is
formed from
polyimide.
-Il-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
The junction 408 optionally houses one or more additional electrical
components
608 including, for example, one or more biosensors, a telemetry unit, a signal
conditioning unit, or the like. In at least some embodiments, the one or more
additional
electrical components 608 are at least partially disposed on the circuit
arrangement 510.
The conductive wires 502, 504a, and 504b can be coupled to the circuit
arrangement 510 in any manner. In preferred embodiments, the conductive wires
502,
504a, and 504b are resistance welded or laser welded to the circuit
arrangement 510. In
other embodiments, the conductive wires 502, 504a, and 504b are crimped,
soldered, or
the like, to the circuit arrangement 510. It may be an advantage to resistance
weld the
conductive wires 502, 504a, and 504b to the circuit arrangement 510 so that
ends of the
conductive wires 502, 504a, and 504b do not need to be ablated prior to
coupling the
conductive wires to the circuit arrangement. It may be an advantage to laser
weld the
conductive wires 502, 504a, and 504b to the circuit arrangement 510 so that
welding can
be performed as an automated, or semi-automated, process.
Figure 7 is a schematic longitudinal cross-sectional view of one embodiment of
one of the conductive wires 502 coupled to one of the conductive wires 504a,
via the
circuit arrangement 510. In Figure 7, the conductive wires 502 and 504a are
shown
coupled to opposite ends of one,of the conductive struts 602. It will be
understood that
the conductive wires 502 and 504 can be coupled anywhere along one of the
conductive
struts 602.
Figure 8 is a schematic perspective close-up view of one embodiment of the
conductive wires 502 coupled to one or more of the conductive wires 504a and
504b via
the circuit arrangement 510. The circuit arrangement 510 is rolled up and
disposed in the
junction 408, which is shown transparently in Figure 8 bounded by a dashed
line, for
clarity of illustration. Figure 9 is a schematic transverse cross-sectional
view of one
embodiment of the rolled-up circuit arrangement 510.
Rolling up the circuit arrangement 510 may reduce the profile of the circuit
arrangement 510, thereby reducing the profile of the junction 408. In at least
some
embodiments, the rolled-up circuit arrangement 510 is potted within the
junction 408. In
at least some embodiments, the rolled-up circuit arrangement 510 is potted
with a hard,
biocompatible resin (e.g., polyurethane, silicone adhesive, epoxy, or the
like) using, for
12-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
example, a casting mold. In at least some embodiments, the resin has a
dielectric constant
of at least 2. For example, in at least some embodiments, a resin formed from
polyimide
may have a dielectric constant of approximately 2.8. As another example, in at
least
some embodiments a resin formed from silicone rubber may have a dielectric
constant of
approximately 3 to 10.
It may be an advantage to pot the circuit arrangement 510 with a hard resin to
provide strain relief for the lead elements 404, 406a, and 406b extending from
the
junction 408. Providing strain relief for the lead elements 502, 504a, and
504b extending
from the junction 408, may reduce, or even eliminate, transmission of
tensile/flex loading
to points of connection between the conductive wires 502, 504a, and 504b and
the circuit
arrangement 510 (e.g., weld joints, or the like).
In at least some embodiments, the conductive wires 502, 504a, and 504b are
coupled to the circuit arrangement 510 after the conductive wires 502 are
coupled to the
electrodes 410 and the conductive wires 504a and 504b are coupled to the
terminals 412a
and 412b, respectively. In at least some embodiments, center-less grinding may
be
performed on one or more of the lead elements 404, 406a, or 406b prior to
coupling the
lead elements 404, 406a, and 406b to the junction 408.
As mentioned above, the multi-lead-element lead body 402 can be used with
either a percutaneous lead or a paddle lead. When the multi-lead-element lead
body 402
is used in conjunction with a percutaneous lead, the lead may be introduced
into a patient
using an epidural needle. In at least some embodiments, a stylet may be used
to facilitate
guidance of the lead within the patient. In at least some embodiments, a
transition tube
may be employed to receive the stylet within the junction 408.
Figure 10 is a schematic longitudinal cross-sectional view of one embodiment
of
the distal lead element 404, the proximal lead element 406a, and the junction
408
therebetween. A lumen 1002 is defined along a longitudinal axis of the distal
lead
element. A lumen 1004 is defined along a longitudinal axis of the proximal
lead element
406a. A transition tube 1006 extends through the junction 408 from the lumen
1002
extending within the distal lead element 404 to the lumen 1004 extending
within the
proximal lead element 406a. In at least some embodiments, the transition tube
1006
enables passage of a stylet through both the proximal lead element 406a and
the distal
-13-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
lead element 404. The stylet may provide stiffness to the lead to facilitate
at least one of
insertion, steering, or implantation of the lead. It will be understood that
the conductive
wires 502, 504a, and 504b are omitted from Figure 10, for clarity of
illustration.
In at least some embodiments, the transition tube 1006 is rolled up within the
circuit arrangement 510 (see e.g., Figure 11). In at least some embodiments,
the
transition tube 1006 is rolled up within the circuit arrangement 510 when the
junction 408
is potted. Once the ends of the transition tube 1006 are coupled to the lumen
1002 of the
distal lead element 404 and the lumen 1004 of the proximal lead element 406a,
a stylet
may be introduced into an access port (not shown) in the proximal lead element
406a and
advanced through the lumen 1004 of the proximal lead element 406a, the
transition tube
1006 of the junction 408, and into the lumen 1002 of the distal lead element
404.
At least some leads, such as the lead shown in Figure 2, are isodiametric to
facilitate sliding of an epidural needle over a proximal end of the trial
stimulation lead
during removal of the epidural needle from a patient once the lead is
positioned within a
patient. In at least some embodiments, the junction 408 (as shown in Figures 4
and 8) has
a circumference that is larger than a circumference of at least one of the
distal lead
element 404, the proximal lead element 406a, or the proximal lead element
406b. In at
least some embodiments, the collective diameter of the proximal lead element
406a and
the proximal lead element 406b is larger than the diameter of the distal lead
element 404.
Thus, the larger-sized junction 408 (or the collective diameter of a plurality
of proximal
lead elements) may hinder, or even prevent, a conventional epidural needle
from sliding
off the proximal end of the lead 400.
Turning now to Figuresl2-14B, in at least some embodiments a kit for providing
electrical stimulation of patient tissue includes the lead 400 and a lead
introducer
configured and arranged for facilitating insertion of the lead 400 into a
patient. In at least
some embodiments, the lead introducer includes a removable outer member
configured
and arranged to receive the lead 400 during insertion of the lead 400 into a
patient.
In at least some embodiments, the outer member is separatable from the trial
lead
by splitting apart. Figure 12 is a schematic perspective view of one
embodiment of a lead
introducer 1200 that includes a outer member 1202 that splits to separate from
the lead
-14-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
400. The outer member 1202 includes a proximal hub 1202a having at least two
pull-
apart tabs 1204 and 1206.
In at least some embodiments, the outer member 1202 is formed from a flexible
material suitable for implantation into a patient 1208 including, for example,
fluorinated
ethylene propylene, polytetrafluoroethylenc, high-density polyethylene,
polyetheretherketone, and the like or combinations thereof. Additionally, one
or more
radiopaque materials may be added including, for example, barium sulfate and
bismuth
subcarbonate, and the like or combinations thereof to facilitate implantation
of the
introducer sheath through the use of one or more medical imaging techniques,
such as
fluoroscopy.
In at least some embodiments, the outer member 1202 includes one or more
weakened regions 1210, such as score lines or perforations, extending along at
least a
portion of a length of the outer member 1202 from between the at least two
pull-apart tabs
1204 and 1206. In at least some embodiments, when the at least two pull-apart
tabs 1204
and 1206 are separated from one another, for example, by pulling each pull-
apart tab
away from the other pull-apart tab(s) in directions approximately orthogonal
to the outer
member 1202, outer member 1202 separates along the one or more weakened
regions
1210.
In at least some embodiments, outer member 1202 is separated into a plurality
of
longitudinal strips while pulling the outer member 1202 proximally along the
lead 1200.
As the outer member 1202 splits apart, the distal end 1202b of the outer
member 1202
moves proximally along the lead 400 (as shown by arrow 1212), with an
increasing
amount of the lead 400 extending through the distal end 1202b of the outer
member 1202.
In at least some embodiments, an undersurface of the outer member 1202
includes a
lubricious coating to facilitate the proximal movement of the outer member
1202.
Eventually, the outer member 1202 may be completely separated into two or more
longitudinal strips, thereby separating completely from the lead 400 and also
from the
patient. In at least some embodiments, the distal ends of the outer member
1202 may be
extracted from the patient as the outer member 1202 is split apart. In at
least some
embodiments, the outer member 1202 may be split apart without causing the lead
400 to
move.
-15-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
In at least some embodiments, an insertion needle includes one or more body
lead
elements that receive the trial lead and that separate from one another after
rcmoval of the
outer member. In at least some embodiments, separation of the one or more body
lead
elements enables removal of the body lead elements from the patient, while the
lead 400
remains within the patient. In at least some embodiments, separation of the
one or more
body lead elements enables removal of the one or more body lead elements from
the
patient without sliding the insertion needle along the proximal end of the
lead 400.
In at least some embodiments, the lead introducer includes an insertion needle
configured and arranged to receive the trial lead and also configured and
arranged for
insertion into the outer member. In at least some embodiments, the insertion
needle
includes at least one body lead clement that defines an open channel defined
along a
length of the insertion needle. In at least some embodiments, when the outer
member is
removed from the insertion needle, the trial lead laterally separates from the
insertion
needle by passing through the open channel.
Figure 13A is a schematic perspective view of one embodiment of the distal
lead
element 404 and a body lead element 1304 of an insertion needle 1306. The body
lead
element 1304 defines an open channel 1308 extending along a length of the body
lead
clement 1304. The open channel 1308 is configured and arranged to receive the
trial
lead. In at least some embodiments, the open channel 1308 extends
substantially entirely
along a length of the body lead element 1304. In at least some embodiments,
the open
channel 1308 extends along a proximal hub 1304a of the body lead element 1304.
In at
least some embodiments, the insertion needle 1306 includes one more additional
body
lead elements.
In at least some embodiments, the open channel 1308 is configured and arranged
to receive the distal lead element 404 during insertion of the lead 400 into
the patient, and
separate from the distal lead element 404 during removal of the body lead
element 1304.
In at least some embodiments, the open channel 1308 separates from the distal
lead
element 404 without moving the distal lead element 404 axially relative to the
body lead
element 1304 of the insertion needle 1306. In at least some embodiments, the
open
channel 1308 separates from the distal lead element 404 by applying enough
lateral force
to at least one of the distal lead element 404 or the body lead element 1304
to pass the
distal lead element 404out through the open channel 1308. In at least some
embodiments,
-16-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
the open channel 1308 has a width that is no less than a diameter of the
distal lead
element 404.
Figure 13B is a schematic transverse cross-sectional view of several different
exemplary embodiments of the open channel 1308. In at least some embodiments,
the
portions of the body lead element 1304 along which the open channel 1308
extends have
a transverse cross-sectional shape that is at least substantially U-shaped
1320. In at least
some embodiments, the portions of the body lead element 1304 along which the
open
channel 1308 extends have a transverse cross-sectional shape that is at least
substantially
horseshoe-shaped 1321. In at least some embodiments, the portions of the body
lead
element 1304 along which the open channel 1308 extends have a transverse cross-
sectional shape that is at least substantially C-shaped 1322. In at least some
embodiments, the portions of body lead element 1304 along which the open
channel 1308
extends have a transverse cross-sectional shape that is at least substantially
arc-shaped
1323.
In at least some embodiments, the outer member 1202 may be rolled or slid
along
a length of the trial lead or the insertion needle. In at least some
embodiments, the lead
introducer includes an insertion needle formed from a plurality of body lead
elements and
an outer member 1202, such as heat shrink tubing, disposed over at least a
portion of the
insertion needle. In at least some embodiments, the insertion needle separates
upon
removal of the outer member. In some embodiments, the insertion needle may be
separated from the trial lead when the body lead elements are partially
separated from one
another. In other embodiments, the insertion needle may be separated from the
trial lead
when the body lead elements are completely detached from one another.
Figure 14A is a schematic longitudinal cross-sectional view of one embodiment
of
a lead introducer 1400 that includes an insertion needle 1402 and an outer
member 1404
disposed over the insertion needle 1402. Figure 14B is a schematic transverse
cross-
sectional view of the lead introducer 1400. The insertion needle 1402 includes
a
proximal end 1406, a distal end 1408, and a longitudinal axis 1410 (shown by a
two-
headed arrow). The insertion needle 1402 also includes a plurality of body
lead elements
1412a and 1412b mated together to define a lumen 1416. In at least some
embodiments,
the body lead elements 1412a and 1412b are mated along the longitudinal axis
1410 of
the insertion needle 1402. In at least some embodiments, the lumen 1416
extends along
-17-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
the longitudinal axis 1410. In at least some embodiments, the lumen 1416
extends along
the longitudinal axis 1410 from the proximal end 1406 to the distal end 1408
of the
insertion needle 1402. In at least some embodiments, the lumen 1416 extends
from a
proximal aperture 1418 at the proximal end 1406. In at least some embodiments,
the
lumen 1416 extends from a distal aperture 1420 at the distal end 1408.
In at least some embodiments, the body lead elements are mated together within
the outer member 1404 such that the body lead elements 1412a and 1412b are at
least
partially separatable from one another when the outer member 1404 is removed.
In at
least some embodiments, the body lead elements 1412a and 1412b at least
partially
separate from one another along a longitudinal axis of the insertion needle
1402. In at
least some embodiments, the body lead elements 1412a and 1412b separate from
one
another such that at least some of the plurality of body lead elements 1412a
and 1412b
remain coupled together. In at least some embodiments, the body lead elements
1412a
and 1412b separate from one another such that at least some of the body lead
elements
1412a and 1412b completely detach from one another. When the body lead
elements
1412a and 1412b are separated (either partially or fully) from one another,
the body lead
elements 1412a and 1412b may be removed from the patient, leaving the lead 400
in
place. In at least some embodiments, when the body lead elements 1412a and
1412b arc
separated (either partially or fully) from one another, the body lead elements
1412a and
1412b may be removed from the patient without sliding the insertion needle
1402 off the
proximal end of the lead 400 through the lumen of the lead introducer 1400.
The outer member 1404 may be formed from any thermoplastic material suitable
for implantation including, for example, polyester, polyolefin, one or more
fluoropolymers (such as fluorinated ethylene propylene,
polytetrafluoroethylene,
polyvinylidene fluoride, or the like or combinations thereof), polyvinyl
chloride,
polychloroprene, silicone elastomer, or the like or combinations thereof.
In at least some embodiments, the outer member 1404 is disposed over at least
a
portion of an outer surface of the insertion needle 1402. In at least some
embodiments,
the outer member 1404 is disposed substantially entirely over the outer
surface of the
insertion needle 1402 distal to the proximal hub 1422. In at least some
embodiments, the
outer member 1404 is disposed entirely over the outer surface of the insertion
needle
-18-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
'1402. In at least some embodiments, the outer member 1404 forms a watertight
seal
along the lumen 1416 of the insertion needle 1402.
In at least some embodiments, once the outer member 1404 is rolled or slid off
the
proximal end 1406 of the insertion needle 1402, the outer member 1404 can be
slid or
rolled over the junction 408. In at least some embodiments, the outer member
1404 can
be stretched to pass over the junction 408. In at least some embodiments, the
outer
member 1404 can be removed by cutting the outer member 1404 along the
longitudinal
axis 1410 of the outer member 1404. In at least some embodiments, the outer
member
1404 can remain encircling the proximal end of the lead 400, external to the
patient.
Figure 15 is a schematic overview of one embodiment of components of an
electrical stimulation system 1500 including an electronic subassembly 1510
disposed
within a control module. It will be understood that the electrical stimulation
system can
include more, fewer, or different components and can have a variety of
different
configurations including those configurations disclosed in the stimulator
references cited
herein.
Some of the components (for example, power source 1512, antenna 1518, receiver
1502, and processor 1504) of the electrical stimulation system can be
positioned on one
or more circuit arrangements or similar carriers within a sealed housing of an
implantable
pulse generator, if desired. Any power source 1512 can be used including, for
example, a
battery such as a primary battery or a rechargeable battery. Examples of other
power
sources include super capacitors, nuclear or atomic batteries, mechanical
resonators,
infrared collectors, thermally-powered energy sources, flexural powered energy
sources,
bioenergy power sources, fuel cells, bioelectric cells, osmotic pressure
pumps, and the
like including the power sources described in U.S. Patent Application No.
7,437,193,
incorporated herein by reference.
As another alternative, power can be supplied by an external power source
through inductive coupling via the optional antenna 1518 or a secondary
antenna. The
external power source can be in a device that is mounted on the skin of the
user or in a
unit that is provided near the user on a permanent or periodic basis.
If the power source 1512 is a rechargeable battery, the battery may be
recharged
using the optional antenna 1518, if desired. Power can be provided to the
battery for
-19-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
recharging by inductively coupling the battery through the antenna to a
recharging unit
1516 external to the user. Examples of such arrangements can be found in the
references
identified above.
In one embodiment, electrical current is emitted by the electrodes 134 on the
paddle or lead body to stimulate nerve fibers, muscle fibers, or other body
tissues near the
electrical stimulation system. A processor 1504 is generally included to
control the
timing and electrical characteristics of the electrical stimulation system.
For example, the,
processor 1504 can, if desired, control one or more of the timing, frequency,
strength,
duration, and waveform of the pulses. In addition, the processor 1504 can
select which
electrodes can be used to provide stimulation, if desired. In some
embodiments, the
processor 1504 may select which electrode(s) are cathodes and which
electrode(s) are
anodes. In some embodiments, the processor 1504 may be used to identify which
electrodes provide the most useful stimulation of the desired tissue.
Any processor can be used and can be as simple as an electronic device that,
for
example, produces pulses at a regular interval or the processor can be capable
of
receiving and interpreting instructions from an external programming unit 1508
that, for
example, allows modification of pulse characteristics. In the illustrated
embodiment, the
processor 1504 is coupled to a receiver 1502 which, in turn, is coupled to the
optional
antenna 1518. This allows the processor 1504 to receive instructions from an
external
source to, for example, direct the pulse characteristics and the selection of
electrodes, if
desired.
In one embodiment, the antenna 1518 is capable of receiving signals (e.g., RF
signals) from an external telemetry unit 1506 which is programmed by a
programming
unit 1508. The programming unit 1508 can be external to, or part of, the
telemetry unit
1506. The telemetry unit 1506 can be a device that is worn on the skin of the
user or can
be carried by the user and can have a form similar to a pager, cellular phone,
or remote
control, if desired. As another alternative, the telemetry unit 1506 may not
be worn or
carried by the user but may only be available at a home station or at a
clinician's office.
The programming unit 1508 can be any unit that can provide information to the
telemetry
unit 1506 for transmission to the electrical stimulation system 1500. The
programming
unit 1508 can be part of the telemetry unit 1506 or can provide signals or
information to
the telemetry unit 1506 via a wireless or wired connection. One example of a
suitable
-20-

CA 02802333 2012-12-10
WO 2012/015621 PCT/US2011/044395
programming unit is a computer operated by the user or clinician to send
signals to the
telemetry unit 1506.
The signals sent to the processor 1504 via the antenna 1518 and receiver 1502
can
be used to modify or otherwise direct the operation of the electrical
stimulation system.
For example, the signals may be used to modify the pulses of the electrical
stimulation
system such as modifying one or more of pulse duration, pulse frequency, pulse
waveform, and pulse strength. The signals may also direct the electrical
stimulation
system 1500 to cease operation, to start operation, to start charging the
battery, or to stop
charging the battery. In other embodiments, the stimulation system does not
include an
antenna 1518 or receiver 1502 and the processor 1504 operates as programmed.
Optionally, the electrical stimulation system 1500 may include a transmitter
(not
shown) coupled to the processor 1504 and the antenna 1518 for transmitting
signals back
to the telemetry unit 1506 or another unit capable of receiving the signals.
For example,
the electrical stimulation system 1500 may transmit signals indicating whether
the
electrical stimulation system 1500 is operating properly or not or indicating
when the
battery needs to be charged or the level of charge remaining in the battery.
The processor
1504 may also be capable of transmitting information about the pulse
characteristics so
that a user or clinician can determine or verify the characteristics.
The above specification, examples and data provide a description of the
manufacture and use of the composition of the invention. Since many
embodiments of
the invention. can be made without departing from the spirit and scope of the
invention,
the invention also resides in the claims hereinafter appended.
-21 -

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Time Limit for Reversal Expired 2018-07-18
Application Not Reinstated by Deadline 2018-07-18
Inactive: Abandoned - No reply to s.30(2) Rules requisition 2017-08-21
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2017-07-18
Inactive: S.30(2) Rules - Examiner requisition 2017-02-21
Inactive: Report - No QC 2017-02-20
Letter Sent 2016-05-24
Request for Examination Received 2016-05-18
All Requirements for Examination Determined Compliant 2016-05-18
Request for Examination Requirements Determined Compliant 2016-05-18
Change of Address or Method of Correspondence Request Received 2015-01-15
Inactive: Cover page published 2013-02-07
Inactive: Notice - National entry - No RFE 2013-01-31
Letter Sent 2013-01-31
Application Received - PCT 2013-01-30
Inactive: IPC assigned 2013-01-30
Inactive: First IPC assigned 2013-01-30
National Entry Requirements Determined Compliant 2012-12-10
Application Published (Open to Public Inspection) 2012-02-02

Abandonment History

Abandonment Date Reason Reinstatement Date
2017-07-18

Maintenance Fee

The last payment was received on 2016-06-09

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Basic national fee - standard 2012-12-10
Registration of a document 2012-12-10
MF (application, 2nd anniv.) - standard 02 2013-07-18 2012-12-10
MF (application, 3rd anniv.) - standard 03 2014-07-18 2014-06-11
MF (application, 4th anniv.) - standard 04 2015-07-20 2015-06-10
Request for examination - standard 2016-05-18
MF (application, 5th anniv.) - standard 05 2016-07-18 2016-06-09
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Past Owners on Record
JOHN MICHAEL BARKER
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 2012-12-09 1 66
Description 2012-12-09 21 972
Drawings 2012-12-09 11 239
Representative drawing 2012-12-09 1 8
Claims 2012-12-09 5 138
Notice of National Entry 2013-01-30 1 193
Courtesy - Certificate of registration (related document(s)) 2013-01-30 1 102
Reminder - Request for Examination 2016-03-20 1 117
Acknowledgement of Request for Examination 2016-05-23 1 175
Courtesy - Abandonment Letter (Maintenance Fee) 2017-08-28 1 176
Courtesy - Abandonment Letter (R30(2)) 2017-10-01 1 164
PCT 2012-12-09 2 60
Correspondence 2015-01-14 2 62
Request for examination 2016-05-17 2 83
Examiner Requisition 2017-02-20 4 215